The Use of Extended Perioperative Low Molecular Weight Heparin to Improve Cancer Specific Survival Following Surgical Resection of Colon Cancer: A Pilot Randomized Controlled Trial.
Phase of Trial: Phase II
Latest Information Update: 29 Nov 2014
At a glance
- Drugs Tinzaparin sodium (Primary)
- Indications Deep vein thrombosis; Pulmonary embolism; Thromboembolism
- Focus Therapeutic Use
- Acronyms PERI-OP
- 10 Jun 2017 Biomarkers information updated
- 12 May 2011 Actual end date (Sep 2010) added as reported by ClinicalTrials.gov.
- 12 May 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.